New process allows labs to use same Pap test vial instead of transferring sample to new vial, thus simplifying workflow INDIANAPOLIS, June 26, 2013 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) ...

Every year, over 600,000 women worldwide are diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 ...

(RTTNews) - Biopharmaceutical company Roche Holding AG (RHHBY), announced on Tuesday that its cobas HPV test for use on the cobas 6800/8800 Systems has been awarded the World Health Organization (WHO) ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved expanded indications for the self-collection of vaginal swabs for HPV tests. The approval will ...

The U.S. Preventive Services Task Force (USPSTF) has pitched an update to its national guidelines for cervical cancer screening—including self-collection tests for HPV among its recommendations for ...

Self-collected menstrual blood samples offered "highly concordant" results with clinician-collected sampling in women who were positive for human papillomavirus (HPV), a researcher reported. In a ...

The Food and Drug Administration this week moved to expand screening for potentially lethal cervical cancer by allowing women to collect test samples themselves, a move that reproductive health ...

There's a new way to screen for high-risk HPV, a viral infection that can lead to cervical cancer. This alternative method of collecting samples for cervical cancer screening doesn't require a ...

Mitchell is an associate professor at the University of Virginia and an NIH-funded nurse scientist. Kueter, a former health journalist and public radio reporter, works as a magazine editor at UVA ...